CRISPR Therapeutics AG
CRSP
M
|
$55.04
-1.99%
-2.03%
1.8M
|
Health Technology
(0.0% 1d) (-20.5% 1m) (16.2% 1y) (0.0% 2d) (0.0% 3d) (-1.3% 7d) (-19.88% volume)
Earnings Calendar: 2024-02-20
Market Cap: $ 4,671,965,329
http://www.crisprtx.com
Sec Filling | Patents | 304 employees
(CH) CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.
genomic genome editing crispr
add to watch list Paper trade email alert is off
Press-releases
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: -0.46%
H: 1.12%
C: -0.2%
conference crispr therapeutics
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: -2.41%
H: 0.23%
C: -0.03%
crispr cell meeting therapeutics therapy
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Published: 2024-03-13 (Crawled : 12:30) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: -0.92%
H: 3.02%
C: 0.23%
crispr therapeutics
CRISPR Therapeutics Proposes New Appointment to the Board of Directors - March 13, 2024
Published: 2024-03-13 (Crawled : 14:30) - biospace.com/
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: -0.92%
H: 3.02%
C: 0.23%
crispr therapeutics
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:30) - globenewswire.com
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.27%
H: 0.53%
C: -0.51%
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: 4.78%
H: 1.22%
C: -0.1%
crispr business year update therapeutics financial results
CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit
Published: 2024-02-15 (Crawled : 14:00) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: 0.9%
H: 13.08%
C: 5.93%
crispr therapeutics
CRISPR Market to Explode: $3.4 Billion Today, $17.8 Billion by 2034, Fueled by Investment Surge | Future Market Insights, Inc.
Published: 2024-02-13 (Crawled : 20:00) - prnewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: 2.63%
H: 4.81%
C: 2.41%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.56%
H: 1.3%
C: 1.22%
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: 2.43%
H: 7.24%
C: 6.02%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 2.87%
H: 2.82%
C: 1.46%
crispr market
CRISPR Therapeutics Announces $280 Million Registered Direct Offering
Published: 2024-02-13 (Crawled : 13:30) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: -5.3%
H: 3.85%
C: 0.54%
crispr million direct offering therapeutics
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)
Published: 2024-02-13 (Crawled : 08:00) - globenewswire.com
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: -5.3%
H: 3.85%
C: 0.54%
first disease cell treatment
Europe Gene Editing Technologies Market Report 2024: Analysis and Forecasts 2023-2032 - Leveraging Collaboration as a Major Key Strategies to Create Opportunities
Published: 2024-02-07 (Crawled : 04:00) - prnewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: 0.18%
H: 0.31%
C: -1.91%
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -0.67%
H: 1.01%
C: 1.01%
europe report collaboration key market
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10